Medical News

Clinical Assessment of Pulmonary Arterial Hypertension in Children with Right Ventricular Base/Apex Ratio

Children with pulmonary arterial hypertension (PAH) have a lower RV end-systolic base/apex (RVES b/a) ratio than age- and gender-matched healthy...

21 Jun, 2018

Email this page
FDC vs. Multipill Regimen: Impact on Medication Adherence and Clinical Outcomes in Elderly Hypertensives

Elderly hypertensive patients administered single-pill fixed dose combination (FDC) rather than multipill regimen have a marked improvement in...

20 Jun, 2018

Email this page
SBP ≥130 mmHg at the Age of 50 Years, a Risk Factor for Dementia

A recent longitudinal study that included over 8000 individuals confirmed that mid-life rather than late-life elevations of systolic blood pressure...

20 Jun, 2018

Email this page
Prasugrel Reduces Stent Atherothrombotic Burden Post-PCI in ACS Patients

Stent placement during percutaneous coronary intervention (PCI) induces atherothrombotic tissue protrusion in acute coronary syndrome (ACS) patients...

12 Jun, 2018

Email this page

Key Trials

Initiation/Uptitration of Sacubitril/Valsartan in HFrEF Patients: Insights from the TITRATION Trial

The TITRATION trial assessed tolerability of initiating/uptitrating sacubitril/valsartan using a conservative or condensed regimen in HFrEF patients...

Evidence with Telmisartan Translated to Real World

As per this study, selectively created non-randomized real-world data might be valuable in establishing supplemental drug indications of medication...

Prasugrel is Superior or Equivalent to Ticagrelor in ACS Patients undergoing PCI: A Systematic Review and Meta-Analysis

Meta-analysis of 9 trials indicates that prasugrel is equivalent or superior to ticagrelor in ACS patients undergoing PCI.

Efficacy and Safety of Sacubitril/Valsartan in HFrEF Patients with Low SBP: Insights from PARADIGM-HF

The present analysis evaluated the efficacy and safety of sacubitril/over enalapril  in HF patients across different levels of SBP.

Slide Library

Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

Email this page
Ambrisentan in PAH

Ambrisentan is a propanoic acid, non-sulfonamide, selective endothelin type A (ETA) receptor antagonist which is used in pulmonary arterial...

Email this page

Our Publications

Azmarda (Sacubitril/Valsartan) FAQs

This booklet on frequently asked questions on sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor (ARNI) provides...

Retefast (Reteplase) Datasheet

This datasheet provides an overview on the pharmacology, clinical efficacy, safety, indications and dosage of reteplase.

The Changing Landscape of CV Risk Reduction - Is LDL Lowering Sufficient: Questions & Answers (Dr. Michael Miller, USA)

Here is a set of questions addressed by Dr. Michael Miller, a renowned cardiologist and lipidologist during the “PROMISE” meet held in India.

Pulmonary Hypertension – An Update

This article summarises the definition, classification, pathogenesis, assessment, prognosis, diagnosis and treatment for PH.

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Managing Your Angina

It explains the causes, risk factors, symptoms and treatment options for angina, as well as the various do’s and don’t’s in a patient-friendly...

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 


Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 


What percent of your patients who need oral anticoagulation, receive warfarin?
22% (2 votes)
11% (1 vote)
0% (0 votes)
11% (1 vote)
44% (4 votes)
Almost all
11% (1 vote)
Total votes: 9